479 related articles for article (PubMed ID: 18316390)
1. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.
Osier FH; Fegan G; Polley SD; Murungi L; Verra F; Tetteh KK; Lowe B; Mwangi T; Bull PC; Thomas AW; Cavanagh DR; McBride JS; Lanar DE; Mackinnon MJ; Conway DJ; Marsh K
Infect Immun; 2008 May; 76(5):2240-8. PubMed ID: 18316390
[TBL] [Abstract][Full Text] [Related]
2. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.
Fowkes FJ; Richards JS; Simpson JA; Beeson JG
PLoS Med; 2010 Jan; 7(1):e1000218. PubMed ID: 20098724
[TBL] [Abstract][Full Text] [Related]
3. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
[TBL] [Abstract][Full Text] [Related]
4. Antibody Profiles to
Ondigo BN; Hamre KES; Frosch AEP; Ayodo G; White MT; John CC
Am J Trop Med Hyg; 2020 Dec; 103(6):2189-2197. PubMed ID: 33124539
[TBL] [Abstract][Full Text] [Related]
5. Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya.
Ibison F; Olotu A; Muema DM; Mwacharo J; Ohuma E; Kimani D; Marsh K; Bejon P; Ndungu FM
PLoS One; 2012; 7(12):e52939. PubMed ID: 23300828
[TBL] [Abstract][Full Text] [Related]
6. Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: kinetics and longevity in absence of re-exposure.
Yman V; White MT; Asghar M; Sundling C; Sondén K; Draper SJ; Osier FHA; Färnert A
BMC Med; 2019 Jan; 17(1):22. PubMed ID: 30696449
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya.
Dent AE; Nakajima R; Liang L; Baum E; Moormann AM; Sumba PO; Vulule J; Babineau D; Randall A; Davies DH; Felgner PL; Kazura JW
J Infect Dis; 2015 Nov; 212(9):1429-38. PubMed ID: 25883384
[TBL] [Abstract][Full Text] [Related]
8. Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria.
Rono J; Osier FH; Olsson D; Montgomery S; Mhoja L; Rooth I; Marsh K; Färnert A
Clin Infect Dis; 2013 Nov; 57(10):1409-16. PubMed ID: 23983244
[TBL] [Abstract][Full Text] [Related]
9. High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria.
Reddy SB; Anders RF; Beeson JG; Färnert A; Kironde F; Berenzon SK; Wahlgren M; Linse S; Persson KE
PLoS One; 2012; 7(2):e32242. PubMed ID: 22363818
[TBL] [Abstract][Full Text] [Related]
10. Boosting antibody responses to Plasmodium falciparum merozoite antigens in children with highly seasonal exposure to infection.
Akpogheneta OJ; Dunyo S; Pinder M; Conway DJ
Parasite Immunol; 2010 Apr; 32(4):296-304. PubMed ID: 20398230
[TBL] [Abstract][Full Text] [Related]
11. Analysis of antibody responses to selected Plasmodium falciparum merozoite surface antigens in mild and cerebral malaria and associations with clinical outcomes.
Mbengue B; Fall MM; Varela ML; Loucoubar C; Joos C; Fall B; Niang MS; Niang B; Mbow M; Dieye A; Perraut R
Clin Exp Immunol; 2019 Apr; 196(1):86-96. PubMed ID: 30580455
[TBL] [Abstract][Full Text] [Related]
12.
Jahnmatz P; Nyabundi D; Sundling C; Widman L; Mwacharo J; Musyoki J; Otieno E; Ahlborg N; Bejon P; Ndungu FM; Färnert A
Front Immunol; 2022; 13():799306. PubMed ID: 35355994
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.
McCarra MB; Ayodo G; Sumba PO; Kazura JW; Moormann AM; Narum DL; John CC
Pediatr Infect Dis J; 2011 Dec; 30(12):1037-42. PubMed ID: 21817955
[TBL] [Abstract][Full Text] [Related]
14. A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria.
Murungi LM; Kamuyu G; Lowe B; Bejon P; Theisen M; Kinyanjui SM; Marsh K; Osier FH
Vaccine; 2013 Aug; 31(37):3936-42. PubMed ID: 23800539
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity.
al-Yaman F; Genton B; Kramer KJ; Chang SP; Hui GS; Baisor M; Alpers MP
Am J Trop Med Hyg; 1996 May; 54(5):443-8. PubMed ID: 8644896
[TBL] [Abstract][Full Text] [Related]
16. Dynamics and role of antibodies to Plasmodium falciparum merozoite antigens in children living in two settings with differing malaria transmission intensity.
Kangoye DT; Mensah VA; Murungi LM; Nkumama I; Nebie I; Marsh K; Cisse B; Bejon P; Osier FH; Sirima SB;
Vaccine; 2016 Jan; 34(1):160-6. PubMed ID: 26541134
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.
Dobaño C; Quelhas D; Quintó L; Puyol L; Serra-Casas E; Mayor A; Nhampossa T; Macete E; Aide P; Mandomando I; Sanz S; Puniya SK; Singh B; Gupta P; Bhattacharya A; Chauhan VS; Aponte JJ; Chitnis CE; Alonso PL; Menéndez C
Clin Vaccine Immunol; 2012 Feb; 19(2):157-66. PubMed ID: 22169088
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
Stanisic DI; Richards JS; McCallum FJ; Michon P; King CL; Schoepflin S; Gilson PR; Murphy VJ; Anders RF; Mueller I; Beeson JG
Infect Immun; 2009 Mar; 77(3):1165-74. PubMed ID: 19139189
[TBL] [Abstract][Full Text] [Related]
19. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan.
Iriemenam NC; Khirelsied AH; Nasr A; ElGhazali G; Giha HA; Elhassan A-Elgadir TM; Agab-Aldour AA; Montgomery SM; Anders RF; Theisen M; Troye-Blomberg M; Elbashir MI; Berzins K
Vaccine; 2009 Jan; 27(1):62-71. PubMed ID: 18977268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
